论文部分内容阅读
目的:研究依达拉奉联合醒脑静对急性脑出血的临床治疗效果。方法:将我院神经内科住院部收治的124例急性脑出血患者作为研究对象,根据治疗方式的不同将其分为观察组和对照组,对照组患者给予醒脑静治疗,观察组患者在对照组的基础上联合依达拉奉治疗,对比分析2组患者治疗前后的总体疗效、血肿情况、神经功能缺损情况以及格拉斯哥GCS昏迷评分。结果:2组患者总有效率比较差异有统计学意义,血肿情况、神经功能评分以及格拉斯哥GCS昏迷评分比较差异有统计学意义。结论:依达拉奉在对急性脑出血的治疗上联合醒脑静,较单一用药临床疗效显著,能够显著改善患者昏迷的情况以及受损神经的功能,促进患者的预后,具有很高的临床使用价值。
Objective: To study the clinical effect of edaravone and xingnaojing on acute cerebral hemorrhage. Methods: A total of 124 patients with acute cerebral hemorrhage admitted to Department of Neurology in our hospital were enrolled in this study. According to the different treatment methods, they were divided into observation group and control group. Control group was given Xingnaojing treatment. Group based on the combination of edaravone treatment, comparative analysis of two groups of patients before and after treatment of the overall efficacy, hematoma, neurological deficit and Glasgow GCS coma score. Results: There was significant difference in the total effective rate between the two groups. The hematoma situation, neurological function score and Glasgow GCS coma score were significantly different. Conclusion: Edaravone combined with Xingnaojing on the treatment of acute intracerebral hemorrhage is more effective than single drug in clinical treatment, which can significantly improve patients’ coma and the function of damaged nerve and promote the prognosis of patients with high clinical Use value.